Featured CME Programs

Presented by Fox Chase Cancer Center, the Temple Lung Center, and the Temple Health Office for Continuing Medical Education

Great therapeutic strides have been made for non-small cell lung cancer (NSCLC). In this CME, renowned specialists from multidisciplinary backgrounds will present innovative treatment modalities that include medical, surgical and radiation oncology, pulmonology, and radiologic options.

The conference explores new care paradigms for early-stage disease, including the CheckMate-816 trial that combines immunotherapy with chemotherapy, and a discussion of eligibility through molecular and PD-L1 testing. Targeted therapies for EGFR mutations or ALK translocations, and EGFR-targeted therapy for locally advanced disease, will also be discussed.

DATE
Saturday, October 5, 2024 

Register

Attached Flyer

TIMES
8:00 AM – 2:15 PM

PROGRAM DIRECTORS

Hossein Borghaei, DO, MS
Chief, Division of Thoracic Medical Oncology 
Professor, Department of Hematology/Oncology 
Gloria and Edmund M. Dunn Chair in Thoracic Oncology 
Fox Chase Cancer Center

Joseph Friedberg, MD, FACS
Thoracic Surgeon-in-Chief, Temple University Health System 
Vice Chair, Surgical Services, Department of Thoracic Medicine and Surgery 
Co-Director, Temple-Fox Chase Cancer Center Mesothelioma and Pleural Disease Program 
Professor, Thoracic Medicine and Surgery, Lewis Katz School of Medicine at Temple University

KEYNOTE SPEAKERS

Julie Brahmer, MD 
Co-Director of the Upper Aerodigestive Department within the Bloomberg~Kimmel Institute for Cancer Immunotherapy; 
Co-Director, Cancer Immunology 
Program Director, Thoracic Oncology Johns Hopkins Medicine

Anne Chiang, MD
PhD Associate Professor; Associate Cancer Center Director for Clinical Initiatives, Yale Cancer Center

PLANNING COMMITTEE

Melissa Culligan, RN, MS, PhD Candidate 
Director of Thoracic Surgery Research at Temple Health; 
Co-Director, Temple-Fox Chase Cancer Center; Mesothelioma and Pleural Disease Program

John Leighton, MD 
Medical Oncology & Hematology, Jefferson Health

Michael Seidman, MD 
Professor, Department of Hematology/ Oncology, Fox Chase Cancer Center

Inquiries

Lucía Tono, PhD
Med: 215-728-3797 
[email protected]

Intended Audience

The program is designed for medical, surgical, and radiation oncologists; urologists; radiologists; primary care physicians; fellows; residents; nurses; and other healthcare providers.

Accreditation Statement

The Temple Health Office for Continuing Medical Education is accredited by the Pennsylvania Medical Society to provide continuing medical education for physicians.

Designation Statement

The Temple Health Office for Continuing Medical Education designates this live activity for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should only claim the credit commensurate with the extent of their participation in the educational activity.

Optimizing Treatment Strategies for Localized and Advanced Genitourinary Malignancies

Presented by Fox Chase Cancer Center and the Temple Health Office for Continuing Medical Education.

The management of advanced kidney, bladder, and prostate cancer is rapidly evolving, and new robotic and minimally invasive surgical techniques are now available. This CME program is designed to address the challenges physicians face in treating these complex cases.

Presented by the nationally recognized Fox Chase Cancer Center genitourinary oncology team—comprising experts in urology, radiation therapy, and medical oncology—this program will cover the latest advancements in surgical techniques, radiation therapies, and medical treatments for both localized and advanced bladder, kidney, and prostate cancers.

DATE
Monday, November 18, 2024

Register

Attached Flyer

TIMES
8:00 AM – 4:00 PM

PROGRAM DIRECTORS

Alexander Kutikov, MD, FACS 
Chair and Professor, Department of Urology 
Roberta R. Scheller Chair in Urologic Oncology
Fox Chase – Temple Urologic Institute Provider 

Daniel M. Geynisman, MD 
Chief, Division of Genitourinary Medical Oncology 
Associate Professor, Department of Hematology/Oncology

TOPICS & PRESENTERS:

J. Ryan Mark, MD, FACS 
Advanced Surgical Techniques for Genitourinary Cancers 

Jessica Karen Wong, MD, MEng 
SABR for Oligometastatic Prostate Cancer and Localized Kidney Cancer 

Pooja Ghatalia, MD
Nuances and Options for the Management of Advanced Bladder Cancer

Fern Anari, MD 
Biochemically Recurrent Prostate Cancer: Treatment Paradigms and New Options 

Matthew R. Zibelman, MD 
Adjuvant therapy in Renal Cell Carninoma

Inquiries

Lucía Tono, PhD
Med: 215-728-3797 
[email protected]

Intended Audience

Medical, surgical and radiation oncologists; thoracic and general surgeons; pulmonologists; gastroenterologists; pathologists; radiologists; fellows/residents/ students; nurses; physician assistants; pharmacists; researchers; and advanced practice clinicians involved in the management of patients with lung cancer and thoracic malignancies.

Accreditation Statement

The Temple Health Office for Continuing Medical Education is accredited by the Pennsylvania Medical Society to provide continuing medical education for physicians. Fox Chase Cancer Center is approved as a provider of nursing continuing professional development by the Pennsylvania State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

Designation Statement

The Temple Health Office for Continuing Medical Education designates this live activity for a maximum of 4 AMA PRA Category 1 Credits™. Physicians should only claim the credit commensurate with the extent of their participation in the educational activity. Fox Chase Cancer Center designates this live activity for a maximum of 4 Hour(s) NCPD (ANCC Contact Hours). Participants should claim only the credit commensurate with the extent of their participation in the activity.